Spectral Medical Inc
TSX:EDT

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
TSX:EDT
Watchlist
Price: 0.495 CAD 2.06% Market Closed
Market Cap: 140m CAD
Have any thoughts about
Spectral Medical Inc?
Write Note

Spectral Medical Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Spectral Medical Inc
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Spectral Medical Inc
TSX:EDT
Common Shares Outstanding
CA$282.8m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
5%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Common Shares Outstanding
CA$2.4m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Common Shares Outstanding
$46m
CAGR 3-Years
-22%
CAGR 5-Years
-10%
CAGR 10-Years
-3%
ESSA Pharma Inc
NASDAQ:EPIX
Common Shares Outstanding
$44.4m
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
49%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Common Shares Outstanding
$143.1m
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
16%
Covalon Technologies Ltd
XTSX:COV
Common Shares Outstanding
CA$24.7m
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
10%
No Stocks Found

Spectral Medical Inc
Glance View

Market Cap
140m CAD
Industry
Biotechnology

Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 31 full-time employees. The firm has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin PMX-20R), which is for the treatment of patients with septic shock and endotoxemia that is measured by the Company’s Endotoxin Activity Assay (EAA). EAA and PMX are both Health Canada licensed and commercially available in Canada. The firm through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. SAMI is targeting the acute RRT market, while DIMI is targeting the chronic RRT market.

EDT Intrinsic Value
0.038 CAD
Overvaluation 92%
Intrinsic Value
Price

See Also

What is Spectral Medical Inc's Common Shares Outstanding?
Common Shares Outstanding
282.8m CAD

Based on the financial report for Sep 30, 2024, Spectral Medical Inc's Common Shares Outstanding amounts to 282.8m CAD.

What is Spectral Medical Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
5%

Over the last year, the Common Shares Outstanding growth was 2%. The average annual Common Shares Outstanding growth rates for Spectral Medical Inc have been 2% over the past three years , 5% over the past five years , and 5% over the past ten years .

Back to Top